Recap: MiMedx Group Q4 Earnings
Portfolio Pulse from Benzinga Insights
MiMedx Group (NASDAQ:MDXG) reported Q4 earnings with an EPS of $0.04, missing estimates by -43.0% against an expected $0.07. Revenue increased by $12.46 million from the previous year. Despite a miss this quarter, past performance shows varied results with a notable beat in Q3 2023.
February 28, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MiMedx Group reported a significant miss in Q4 earnings with an EPS of $0.04, underperforming against estimates by -43.0%. However, revenue saw a year-over-year increase.
The significant miss in earnings estimates is likely to negatively impact investor sentiment in the short term, despite the increase in revenue. Historical data shows that past earnings performance, such as the beat in Q3 2023, can influence stock price movement. However, the current miss may overshadow past positive performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100